Literature DB >> 30719585

Pharmacokinetics, Tissue Distribution and Excretion of Ag2S Quantum Dots in Mice and Rats: the Effects of Injection Dose, Particle Size and Surface Charge.

Jaber Javidi1, Azadeh Haeri1, Fatemeh Nowroozi1, Simin Dadashzadeh2,3.   

Abstract

PURPOSE: We systematically investigated the effects of injection dose, particle size and surface charge on the pharmacokinetics, tissue distribution and excretion of Ag2S quantum dots (Qds) in rats and mice.
METHODS: Three different doses of Ag2S Qds with similar size and composition were administrated to rats and mice. The effect of size and surface charge was investigated with the injection of three sizes (5, 15 and 25 nm) of Ag2S Qds possessing similar surface charge, as well as 5 nm Qds with a positive surface charge.
RESULTS: Results indicated that pharmacokinetics and biodistribution of Ag2S Qds were strongly dose, particle size and surface charge dependent. By increasing the dose from 0.5 to 4.0 mg/kg, mean residence time (MRT) and apparent volume of distribution at steady state (Vss) were increased while clearance (CL) was decreased. Qds with a negative surface charge had significantly larger MRT and Vss values than positively charged particles, but their CL was about 50% lower than that of positively charged ones. By increasing Qds size from 5 to 25 nm, CL was increased while MRT and AUC were decreased.
CONCLUSIONS: This study establishes comprehensive principles for the rational design and tailoring of Ag2S Qds for biomedical applications. Graphical Abstract The effects of injection dose, particle size and surface charge on pharmacokinetics and tissue distribution of Ag2S Qds after intravenous injection into rats and mice were investigated.

Entities:  

Keywords:  Ag2S; excretion; pharmacokinetics; quantum dots; tissue distribution

Mesh:

Substances:

Year:  2019        PMID: 30719585     DOI: 10.1007/s11095-019-2571-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  32 in total

Review 1.  Near-infrared quantum dots for deep tissue imaging.

Authors:  Ravindran Girija Aswathy; Yasuhiko Yoshida; T Maekawa; D Sakthi Kumar
Journal:  Anal Bioanal Chem       Date:  2010-03-29       Impact factor: 4.142

Review 2.  Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects.

Authors:  Jin-Wook Yoo; Elizabeth Chambers; Samir Mitragotri
Journal:  Curr Pharm Des       Date:  2010-07       Impact factor: 3.116

3.  Characterization of CdHgTe/CdS QDs for near infrared fluorescence imaging of spinal column in a mouse model.

Authors:  Haiyan Chen; Sisi Cui; Zhenzhen Tu; Jinzi Ji; Jun Zhang; Yueqing Gu
Journal:  Photochem Photobiol       Date:  2010-11-15       Impact factor: 3.421

4.  Morphologic demonstration of receptor-mediated endocytosis of epidermal growth factor by isolated bile duct epithelial cells.

Authors:  M Ishii; B Vroman; N F LaRusso
Journal:  Gastroenterology       Date:  1990-05       Impact factor: 22.682

5.  Renal clearance of quantum dots.

Authors:  Hak Soo Choi; Wenhao Liu; Preeti Misra; Eiichi Tanaka; John P Zimmer; Binil Itty Ipe; Moungi G Bawendi; John V Frangioni
Journal:  Nat Biotechnol       Date:  2007-09-23       Impact factor: 54.908

Review 6.  Pharmacokinetics and biodistribution of nanoparticles.

Authors:  Shyh-Dar Li; Leaf Huang
Journal:  Mol Pharm       Date:  2008-07-09       Impact factor: 4.939

7.  PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel.

Authors:  Yong Zhang; Meirong Huo; Jianping Zhou; Shaofei Xie
Journal:  Comput Methods Programs Biomed       Date:  2010-02-21       Impact factor: 5.428

Review 8.  Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.

Authors:  Michelle Longmire; Peter L Choyke; Hisataka Kobayashi
Journal:  Nanomedicine (Lond)       Date:  2008-10       Impact factor: 5.307

9.  Preparation and bioapplication of high-quality, water-soluble, biocompatible, and near-infrared-emitting CdSeTe alloyed quantum dots.

Authors:  Guo-Xi Liang; Miao-Miao Gu; Jian-Rong Zhang; Jun-Jie Zhu
Journal:  Nanotechnology       Date:  2009-09-18       Impact factor: 3.874

10.  Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.

Authors:  Lajos Balogh; Shraddha S Nigavekar; Bindu M Nair; Wojciech Lesniak; Chunxin Zhang; Lok Yun Sung; Muhammed S T Kariapper; Areej El-Jawahri; Mikel Llanes; Brian Bolton; Fatema Mamou; Wei Tan; Alan Hutson; Leah Minc; Mohamed K Khan
Journal:  Nanomedicine       Date:  2007-10-24       Impact factor: 5.307

View more
  4 in total

1.  Renally Excretable Silver Telluride Nanoparticles as Contrast Agents for X-ray Imaging.

Authors:  Lenitza M Nieves; Yuxi C Dong; Derick N Rosario-Berríos; Katherine Mossburg; Jessica C Hsu; Gwendolyn M Cramer; Theresa M Busch; Andrew D A Maidment; David P Cormode
Journal:  ACS Appl Mater Interfaces       Date:  2022-07-22       Impact factor: 10.383

2.  Comparison of silver nanoparticle-induced inflammatory responses between healthy and metabolic syndrome mouse models.

Authors:  Lisa Kobos; Saeed Alqahtani; Li Xia; Vincent Coltellino; Riley Kishman; Daniel McIlrath; Carlos Perez-Torres; Jonathan Shannahan
Journal:  J Toxicol Environ Health A       Date:  2020-04-12

3.  Oleic acid-based nanosystems for mitigating acute respiratory distress syndrome in mice through neutrophil suppression: how the particulate size affects therapeutic efficiency.

Authors:  Huang-Ping Yu; Fu-Chao Liu; Ani Umoro; Zih-Chan Lin; Ahmed O Elzoghby; Tsong-Long Hwang; Jia-You Fang
Journal:  J Nanobiotechnology       Date:  2020-01-31       Impact factor: 10.435

4.  Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice.

Authors:  Chia-Chih Liao; Huang-Ping Yu; Shih-Chun Yang; Ahmed Alalaiwe; You-Shan Dai; Fu-Chao Liu; Jia-You Fang
Journal:  J Nanobiotechnology       Date:  2021-02-15       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.